<DOC>
	<DOCNO>NCT00139594</DOCNO>
	<brief_summary>This extension study design ass long-tem tolerability safety licarbazepine patient complete 6-week double-blind study CLIC477D2303 .</brief_summary>
	<brief_title>Open Label Extension Study Licarbazepine Treatment Manic Episodes Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>write informed consent provide prior participation extension study successful completion study CLIC477D2303 cooperation willingness comply study requirement premature discontinuation study CLIC477D2303 failure comply study CLIC477D2303</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bipolar disorder , manic episode/treatment/licarbazepine</keyword>
</DOC>